Cresco Labs (CRLBF) Cash & Current Investments (2019 - 2026)
Cresco Labs (CRLBF) reported Cash & Current Investments of $63.6 million for Q1 2026, up 1709.65% on a YoY basis from $3.5 million in Q1 2025, and down 30.21% quarter-over-quarter from $91.1 million in Q4 2025.
Cresco Labs (CRLBF) Cash & Current Investments (2019 - 2026) Analysis & Trends
Cresco Labs has reported Cash & Current Investments for 8 years, with the latest figure at $63.6 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 1709.65% year-over-year to $63.6 million; the trailing twelve-month figure through Mar 2026 stood at $63.6 million (up 431.64% YoY), and the FY2025 full-year result was $91.1 million, up 2548.62% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $63.6 million, down from $91.1 million in the prior quarter.
- The five-year high for Cash & Current Investments was $116.0 million in Q2 2024, with the low at $1.7 million in Q1 2024.
- Historically, Cash & Current Investments has averaged $33.5 million across 5 years, with a median of $3.4 million in 2024.
- Annual changes were most pronounced in 2022 — Cash & Current Investments sank 99.0% — and 2025, when it soared 2548.62%.
- Cresco Labs' Cash & Current Investments stood at $2.3 million in 2022, then surged by 4663.83% to $108.5 million in 2023, then tumbled by 96.83% to $3.4 million in 2024, then soared by 2548.62% to $91.1 million in 2025, then sank by 30.21% to $63.6 million in 2026.
- The last three Cash & Current Investments figures came in at $63.6 million (Q1 2026), $91.1 million (Q4 2025), and $33.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | 63.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.57 Mn |
| Dec 31, 2025 | 91.09 Mn |
| Sep 30, 2025 | 33.29 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 115.95 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 108.52 Mn |
| Sep 30, 2022 | 2.28 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 2.60 Mn |
| Jun 30, 2021 | 131.04 Mn |
| Mar 31, 2021 | 258.97 Mn |
| Dec 31, 2020 | 140.77 Mn |
| Sep 30, 2020 | 57.69 Mn |
| Mar 31, 2020 | 68.24 Mn |
| Dec 31, 2019 | 49.10 Mn |